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A B S T R A C T
Purpose: Previous studies have suggested a role for the toxic elements lead (Pb), mercury (Hg) and cadmium
(Cd) in the development of insulin resistance and hypertension. Increased blood Pb levels have been reported
after bariatric surgery and weight loss. As about 80% of patients undergoing bariatric surgery are women, most
of them of childbearing age, there are concerns regarding fetal exposure to toxic trace elements. We measured
whole blood Hg, Pb and Cd concentrations in morbidly obese patients before and 12 months after Roux-en-Y
gastric bypass (RYGB).
Patients and methods: Forty-six patients eligible for bariatric surgery were recruited at Innlandet Hospital Trust,
Norway (2012–2014). The majority were women and 54% were of reproductive age. Whole blood samples were
collected prior to and 12 months after surgery. Trace element concentrations were measured using mass spec-
trometry (HR-ICP-MS).
Results: Median whole blood Pb concentrations increased by 73% during the 12 months study period while Hg
and Cd decreased by 31% and 27%, respectively. We found a negative correlation between Pb levels before
surgery and BMI (p=0.02). Before surgery patients with hypertension had significantly higher median whole
blood Hg levels compared to patients with normal blood pressure (p < 0.001).
Conclusion: One year after bariatric surgery, the median whole blood Pb concentration was increased, while Hg
and Cd concentrations were decreased. The majority of bariatric surgery patients are women of reproductive age
and weight loss is associated with improved fertility. As even low dose Pb exposure during fetal life is associated
with negative effects on the central nervous system, the observed increase in whole blood Pb after weight loss
causes concern. Further studies are needed to elucidate these observations.
1. Introduction
Globally there is an increasing prevalence of obesity defined by a
BMI≥ 30 kg/m2, which is known to predispose to comorbidities like
type 2 diabetes, hypertension, dyslipidemia and coronary heart disease
[1]. Epidemiologic studies have suggested a role for the toxic metals
lead (Pb), mercury (Hg) and cadmium (Cd) in the development of
metabolic syndrome [2]. All three elements have been shown to in-
teract with obesity in various ways, like substituting for essential trace
elements or increasing the risk for developing diabetes [3] and hy-
pertension [2,4,5].
As weight loss is associated with improvement in metabolic function
[6], an increasing number of patients are referred to bariatric surgery
[7]. Increased blood Pb levels have been reported after bariatric surgery
in women [8], and there are concerns regarding the redistribution of
mercury (methylmercury) into blood after postoperative loss of fat
tissue [9].
About 80% of the patients undergoing bariatric surgery are women,
many in their childbearing age [10]. Weight loss is associated with
improved fertility rates [11], however, bariatric surgery is also re-
garded as a risk factor for adverse pregnancy outcomes [12], particu-
larly due to disturbances in micronutrient status [13]. Exposure to toxic
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elements during fetal life and infancy may have serious long-term
health consequences for the child, and cause damage to the central
nervous system, the lungs and the kidneys [14–17].
We have studied changes in whole blood Hg, Pb and Cd con-
centrations before and 12 months after Roux-en-Y gastric bypass
(RYGB) in a group of patients with a BMI≥ 35, where the majority
were women of reproductive age.
2. Materials and methods
2.1. Study population
Patients aged 18–60 years eligible for bariatric surgery due to a BMI
> 40 kg/m2 or a BMI > 35 with serious weight related comorbidities
like type 2 diabetes or cardiovascular disease, were consecutively re-
cruited at Innlandet Hospital Trust, Gjøvik, Norway, during 2012–2014.
Exclusion criteria were major psychiatric disorders, serious somatic
disorders not related to obesity, alcohol or drug addiction, former
obesity surgery and other major abdominal surgery. The enrolled pa-
tients got an initial brief dietetic counselling six months before surgery.
At the end of this period, they attended an eight week course on life-
style changes, followed by bariatric surgery. The surgical technique
used was laparoscopic Roux-en-Y gastric bypass (RYGB), which in-
volves transection of the upper part of the stomach leaving about
30mL, which is anastomosed with the distal jejunum, resulting in by-
pass of the remaining major part of the stomach, duodenum and
proximal jejunum [18]. Reduced size of the functional stomach results
in earlier satiety and thus restricted food intake. Furthermore, the food
in this stomach pouch bypasses the duodenum and enters directly into
the distal jejunum, leading to reduced absorption in the small intestine
[18].
After surgery the patients were recommended daily supplementa-
tion with iron (100mg), calcium (1000mg) and vitamin D (20 μg) for 6
months, intramuscular vitamin B12 injections (1 mg) every third
month, and lifelong daily multivitamin/mineral supplements.
Ethical approval of the protocol was obtained by the Regional
Committee for Medical and Health Research Ethics (REK), Region
South-East, Norway, ref. number 2012/1394. The study was conducted
in accordance with the Declaration of Helsinki, and written informed
consent was obtained from all patients before enrolment.
2.2. Sample collection, preparation and analysis
Whole blood samples were collected immediately before surgery
and 12 months after surgery. The samples were obtained from the cu-
bital vein between 8:00 and 10:30 a.m. and collected in Vacuette Trace
Elements Sodium Heparin tubes (Greiner Bio-One) for trace element
analyses. The samples were stored at −20 °C before analysis.
Approximately 0.7mL blood was transferred to metal-free 18mL
teflon tubes. The exact weight of each sample was measured and con-
verted back to volume by multiplying with 1.06 g/mL (the average
density of whole blood). The samples were acidified with 1.0 mL 65%
(V/V) ultrapure nitric acid, produced in-house from p.a. quality nitric
acid (Merck, Darmstadt) using a sub-boiling distillation system
(SubPur, Milestone, Shelton, CT). The samples were then digested using
a high performance microwave reactor (UltraClave, Milestone).
Digested samples were decanted into pre-cleaned 15mL polypropylene
vials (VWR, USA) and diluted with ultrapure water (Purelab Option-Q,
Elga) to achieve a final acid concentration of 0.6M.
Trace element concentrations were measured using high resolution
inductively coupled plasma mass spectrometry (HR-ICP-MS, Thermo
Finnigan Element 2, Bremen). The sample introduction system con-
sisted of an SC2-DX auto-sampler with ULPA filter, a prepFAST system,
a concentric PFA-ST nebulizer coupled to a quartz cyclonic micro mist
Scott spray chamber with auxiliary gas port, aluminium skimmer and
sample cones, and an O-ring-free quartz torch and 2.5 mm injector
(Elemental Scientific, Omaha, NE). The radio frequency power was set
to 1350W; nebulizer and T-connection sample gas flow were 0.75 L/
min, and 0.55 L/min, respectively. Cooling gas flow was 15.5 L/min,
auxiliary gas flow was 1.1mL/min and additional gas consisted of 10%
methane in argon with flow rate of 0.01 L/min.
Two multi-element stock solutions (Elemental Scientific, Omaha,
NE) were used, one serving as a calibrating solution and the other as a
quality control. These solutions were matrix matched with the blood
samples for acid strength (0.6M ultrapure nitric acid), and by adding
160mg/L sodium and 115mg/L potassium (Spectrapure Standards,
Oslo). Corrections for instrumental drift were done by repeated mea-
surements of one of the multielement standards. The stability of the
instrument was checked by inspection of the argon signal and mea-
surements of 1 μg/L rhenium added as an internal standard through the
prepFAST system. Repeated analysis of a certified reference material
(Seronorm Level 1, Sero, Norway) was used to verify the accuracy of the
instrument.
2.3. Statistical analysis
Results are presented as mean and standard deviation (SD), com-
pared by Student’s t-test or Anova, and median and interquartile range
(IQR), compared by Mann-Whitney U test or Kruskal-Wallis test. Chi-
square test was used for categorical data. Spearman correlations were
used to explore relationships between data. Tests of normality were
Kolmogorov-Smirnov and Shapiro-Wilk.
Graphical illustration of the relationship between age and whole
blood Pb and Hg, alcohol intake and Pb, and smoking history and Cd
was obtained by generalized additive models (GAM).
The SPSS statistical program (version 23) and the packages “mgcv”
in R®, version 3.3 (The R Foundation for Statistical Computing) were
used for the statistical analyses. Two-sided p-values< 0.05 were con-
sidered statistically significant.
3. Results
The study population included 46 patients (age range 27–59 years)
with baseline characteristics given in Table 1. The majority were
women, of whom 21/39 (54%) were of reproductive age (< 45 years).
At inclusion, both women and men tended to eat more meat than
fish and seafood (Table 1). Nine of 39 women (23%) and one of six men
(17%) were daily smokers (p=0.08) (Table 1), and the percentage
declined from inclusion to 12 months after surgery (22% versus 3%).
The number of patients who reported use of alcohol more than once a
month, remained essentially unchanged from inclusion to 12 months
after bariatric surgery (43% versus 41%).
Total mean weight loss from inclusion to 12 months after bariatric
surgery was 42.5 (SD 11.9) kg, (range 13.4–68.7 kg). Approximately
25% of the weight loss was achieved by dieting and exercise before
surgery (mean 10.3 (SD 4.6) kg), and 75% was achieved after surgery
Table 1
Baseline characteristics in patients admitted for gastric bypass (n=46).
Female gendera 39/46 (85)
Age, yearsb 43.9 (9.1)
Body mass indexb 42.4 (3.6)
Education, yearsb 13 (3)
Full time occupationa 23/45 (51)
Married/cohabitanta 38/44 (86)
Daily intake of meat, gramsb 164 (60)
Daily intake of fish/seafood, gramsb 80 (49)
Daily smokera 10/45 (22)
Alcohol intake ≥ 1 per montha 20/46 (43)
Current diagnosis of hypertensiona 15/44 (34)
Current diagnosis of diabetesa 7/44 (16)
a Data are expressed as number (%).
b Data are expressed as mean (SD).
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(mean 32.3 (SD 10.6) kg). There was a mean reduction of 33% in BMI
from inclusion to 12 months postoperatively (mean BMI 27.8 (SD 3.4),
with no gender difference (p=0.81).
4. Toxic element concentrations before and 12 months after
bariatric surgery
Whole blood Pb, Hg and Cd concentrations changed significantly
during the observation period of 12 months (Table 2, Table 4). Median
Pb concentration increased by 73%, while median Hg and Cd con-
centrations decreased (by 31% and 27%, respectively).
BMI was significantly inversely correlated to whole blood Pb before
surgery (rho=-0.34, p=0.02), while only weak, negative correlations
were observed for BMI and Hg and Cd (p > 0.12). Age was sig-
nificantly correlated to whole blood concentrations of Pb (rho= 0.39,
p=0.007) and Hg (rho=0.53, p < 0.001) before surgery (Fig. 1), but
not to Cd concentrations (rho=-0.04, p=0.8).
Reported alcohol intake at inclusion was positively related to whole
blood Pb before surgery (rho= 0.44, p=0.003), with a dose-response
relationship between intake of alcohol in units and whole blood Pb, as
shown by GAM corrected for age (Fig. 2). Alcohol intake was also the
strongest predictor for Pb in a multiple linear regression model, which
additionally included gender, age, smoking history, fish intake, edu-
cation, BMI at inclusion and weight reduction before surgery (Table 3).
Women had slightly higher median Hg levels 1.12 (IQR 0.73, 1.50)
μg/L than men median Hg 0.94 (IQR 0.66, 1.01) μg/L before surgery,
but this difference was not significant (p=0.14). However, in the
multiple linear regression model, gender was a strong predictor for
whole blood Hg followed by intake of fish and seafood (Table 3).
Before surgery, patients with hypertension (n=15) had sig-
nificantly higher median whole blood Hg 1.76 (IQR 1.13, 2.01) μg/L
compared to patients with normal blood pressure median Hg 1.00 (IQR
0.65, 1.17) μg/L, p < 0.001. This difference was reduced after surgery
and was no longer significant (p=0.19). No differences were observed
for Pb and Cd concentrations in patients with a diagnosis of hy-
pertension vs. those without this diagnosis.
Smoking history at inclusion was strongly correlated to whole blood
Cd before surgery (rho= 0.69, p < 0.001) (Fig. 3), and was the
strongest predictor for Cd in the multiple linear regression model
(Table 3).
At inclusion seven patients had a diagnosis of diabetes; no differ-
ences in Pb, Hg or Cd concentrations before or after surgery were seen
in diabetic versus non-diabetic patients (p > 0.12).
5. Discussion
Studies have proposed a connection between toxic elements, dia-
betes and obesity [19,20].When these elements substitute for essential
micronutrients like iron, zinc or potassium, they may catalyze oxidative
stress reactions and damage cells, enzymes and genes [21]. Pancreatic
beta-cells may be prone to toxic element-induced oxidative stress due to
their high expression of metal transporters and low expression of an-
tioxidants [22].
Metal neurotoxicity on brain function and signaling related to ap-
petite and satiety may also be involved in development of obesity. Since
brain development is affected by both lead and cadmium a disruption in
energy balance could result from dysregulated appetite and satiety re-
sponse, with consequent increased caloric intake [23].
Toxic metals such as Cd, Hg and Pb also cause damage by func-
tioning as endocrine disruptors that alter physiological functions. Both
Cd and Hg stimulate progesterone synthesis [24].
In the present study, we found the whole blood Pb concentration to
be negatively related to BMI in a population of obese Norwegian adults.
The median whole blood Hg concentration was substantially higher in
patients with hypertension, while no associations were found for any of
these metals as related to a diagnosis of diabetes.
One year after bariatric surgery with a mean weight loss of 32.3 kg,
median whole blood Pb increased by 73%, while median Hg and Cd
concentrations declined by 31 and 27%, respectively. The majority of
Table 2
Whole blood lead, mercury and cadmium concentrations before and 12 months after bariatric surgery (n= 46).
Parametersa Before surgery N=46 12 months after surgery N=46 P valueb
Whole blood lead, μg/L 6.73 (4.13, 9.48) 1.58 – 17.78 11.66 (7.96, 14.91) 4.73 – 22.94 <0.001
Whole blood mercury, μg/L 1.08 (0.72, 1.46) 0.38 – 3.97 0.74 (0.57, 1.31) 0.26 – 3.60 0.001
Whole blood cadmium, μg/L 0.33 (0.21, 0.56) 0.12 – 1.96 0.24 (0.16, 0.58) 0.08 – 1.07 0.003
a Data are expressed as median (IQR) and Range.
b Compared by Wilcoxon Signed Rank Test.
Fig. 1. The association of age with whole blood lead (Pb) and mercury (Hg)
concentrations by a generalized additive model (GAM).
The solid line shows the fitted model and the area between the dotted lines
indicate 95% confidence interval.
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the patients were women of reproductive age (< 45 years). As weight
loss is associated with increased fertility, the increase in whole blood Pb
concentration may be of concern for pregnancy outcome.
In our population of young and middle aged obese patients, age was
significantly positively correlated to whole blood Pb and Hg, while BMI
was negatively correlated to whole blood Pb before surgery. Weak
negative, however not significant, correlations between BMI and Hg
and Cd were observed. Published studies on the correlation between
BMI and toxic metals have shown ambiguous results [3,25–27]. How-
ever, in large population studies including the US NHANES, an inverse
correlation between BMI and whole blood Hg [25], whole blood and
urine Pb [3,26] and Cd [3,27] have been reported. Pb and Cd accu-
mulate progressively in the body with a long biological half-life of
15–30 years [28,29], while Hg has a relatively short half-life of ap-
proximately 50 days [30]. While both BMI and the levels of Hg, Pb and
Cd tend to increase with age, these inverse relations have been difficult
to explain, but seem to be independent of age and gender [3].
Fig. 2. The association of alcohol intake with whole blood lead (Pb) con-
centrations by generalized additive model (GAM), adjusted for age.
The solid line shows the fitted model and the area between the dotted lines
indicate 95%.
Table 3
Determinants of whole blood lead, mercury and cadmium before bariatric
surgery (n=46) by multiple linear regressiona.
Variables included in
the model
Whole blood lead Whole blood
mercury
Whole blood
cadmium
Beta P Beta P Beta P
Genderb −0.06 0.77 −0.43 0.03 0.04 0.80
Age, years 0.17 0.36 0.27 0.14 −0.05 0.74
Alcohol intakec 0.47 0.006 0.23 0.16 0.01 0.95
Smoking historyd 0.04 0.80 −0.30 0.09 0.49 0.02
Intake of fish and
seafood, grams/
week
0.03 0.88 0.31 0.08 0.01 0.96
Education, years 0.31 0.05 −0.20 0.21 0.06 0.71
BMI at inclusion −0.22 0.23 −0.15 0.41 −0.28 0.18
Weight reduction,
after dieting, kg
0.21 0.25 0.09 0.62 0.05 0.80
a Multiple linear regression; the model contains gender and the initial weight
reduction after dieting, in addition to the parameters listed in the table.
b Gender: Female, male.
c Alcohol intake: Never, rarely, 1/month, ≥2/month and ≥1/week.
d Smoking: Never smoker, former smoker and current smoker.
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5.1. Lead
Compared to French adults [31], median whole blood Pb was lower
in obese Norwegian adults both before and after surgery (Table 4).
However, after bariatric surgery, obese Norwegian women of re-
productive age had higher median whole blood Pb concentrations
compared to age-matched Scandinavian women [32–34] (Table 4).
A substantial increase of more than 70% in median whole blood Pb
concentration was observed after bariatric surgery, in parallel to the
weight loss of about 30 kg. The strongest predictor for whole blood Pb
at inclusion was use of alcohol, which is in accord with reports by
others [33]. Alcohol habits remained essentially unchanged from in-
clusion to 12 months after bariatric surgery.
More than 90% of Pb is stored in bone [28]. Weight loss has been
shown to increase bone turnover, thereby mobilizing Pb with resulting
higher blood levels [8,35]. For example, in a small group of women
(n=17) with a mean weight loss of 37.4, (SD 9.3) kg, whole blood Pb
concentrations increased by 90% from mean 1.9 (SD 1.4) μg/dL to 3.9
(SD 3.4) μg/dL after six months [8], an increase comparable to what we
observed.
As about 80% of the patients undergoing bariatric surgery are
women, many of childbearing age [10], the increase in whole blood Pb
concentrations observed one year after surgery is of concern. Weight
loss is associated with improved fertility rates [11]. There is no inter-
national consensus concerning the ideal time to conception after bar-
iatric surgery, but the standard recommendation is to delay pregnancy
for at least 1–1.5 years after surgery [36]. During pregnancy, maternal
blood Pb concentrations increase, and Pb is easily transferred across the
placenta to the fetus [37]. After birth, Pb is secreted into breast milk
[37,38]. As even low levels of Pb exposure in children are associated
with neurodevelopmental deficits [39,40], the observed increase in
whole blood Pb concentrations after bariatric surgery is worrying.
5.2. Mercury
Compared to French adults [31], median whole blood Hg con-
centrations were lower in obese Norwegian adults both before and after
surgery (Table 4). Obese Norwegian women of reproductive age had
lower median Hg concentrations both before and after bariatric surgery
compared to age-matched Scandinavian women [32–34] (Table 4).
Before surgery, gender and seafood intake were the strongest de-
terminants for Hg, relations also reported by others [32]. We observed a
higher median whole blood Hg concentration in patients with hy-
pertension before surgery. Mercury has numerous negative vascular
effects and the clinical consequences of mercury toxicity include,
among others, hypertension [5].
There are no published data on Hg levels after bariatric surgery. We
observed a reduction in whole blood Hg after bariatric surgery induced
weight loss. The reasons for this reduction is unknown, however, gastric
bypass surgery reduces the size of the functional stomach and results in
restricted food intake. As whole blood Hg has a relatively short half-life
of approximately 50 days [30], a reduced intake of fish and seafood
after surgery may be responsible for the reduced whole blood Hg con-
centrations.
5.3. Cadmium
Compared to French adults [31], median whole blood Cd con-
centrations were lower in obese Norwegian adults both before and after
surgery (Table 4). Median Cd concentrations were higher in obese
Norwegian women before surgery compared to other Scandinavian
women [32–34] (Table 4). After surgery, median Cd levels were re-
duced in obese women resembling age-matched Danish women [34]
(Table 4).
The strongest determinants for Cd concentrations before surgery
were use of tobacco, as reported earlier [32,33,41]. There are no
published data on whole blood Cd concentrations after bariatric sur-
gery. Whole blood Cd is an established marker of Cd exposure and is
reported to also reflect short term fluctuations in exposure [29]. As the
percentage of daily smokers was substantially reduced one year after
surgery, this may partially explain the observed reduction in whole
blood Cd concentrations.
6. Conclusion
In this study of obese Norwegian adults whole blood concentrations
of Pb, Hg and Cd were weakly negatively related to BMI. However, the
weight loss induced by bariatric surgery increased median whole blood
Pb significantly, whereas it reduced Hg and Cd concentrations as
measured one year after surgery. Weight loss is known to increase
fertility, and as the majority of bariatric surgery patients are women of
reproductive age, this increase in whole blood PB concentrations is of
concern.
Interestingly, patients with hypertension had significantly higher
median whole blood Hg concentrations before surgery, but not post-
operatively, while no differences in Pb, Hg or Cd concentrations were
seen as related to a diagnosis of diabetes.
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Fig. 3. The association of smoking history with whole blood lead (Pb) con-
centrations by generalized additive model (GAM), adjusted for age.
The solid line shows the fitted model and the area between the dotted lines
indicate 95%.
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